We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6066:HKEXCSC Financial Co., Ltd. Class H Analysis

Data as of 2026-03-16 - not real-time

HK$11.27

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CSC Financial is trading at HK$11.27, well below its 20‑day SMA of HK$11.91 and the 50‑day/200‑day SMAs around HK$12.5, indicating an bearish price bias. The 14‑day RSI sits at 33.7, just above oversold territory, suggesting limited downside momentum and a potential for a short‑term bounce. MACD remains in bearish territory with a negative histogram, reinforcing the current downtrend. The stock is perched near a technical support of HK$11.03 and faces resistance around HK$13.08, leaving a modest upside of roughly 45% to the DCF‑derived fair value. Valuation multiples are attractive: a trailing P/E of 9.8 versus an industry average of 16.35 and a price‑to‑book below 1.0, positioning the shares as a clear value play.
Fundamentally, revenue surged 53% year‑over‑year to HK$24.9 bn, while gross, operating and profit margins remain robust at 58%, 47% and 40% respectively. The company generates strong cash flow (HK$69.3 bn operating cash) and holds a net‑cash position despite a headline debt‑to‑equity ratio of 297%, mitigating balance‑sheet concerns. Dividend sustainability looks solid, with a 3.21% yield and a modest 25% payout ratio supported by ample earnings and cash. Volatility is elevated at 26.5% over the past 30 days, but beta is low at 0.24, indicating limited systematic risk. Exposure to China’s capital‑markets sector introduces medium regulatory and geographic risks, while the HK‑listed share enjoys reasonable liquidity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical oversold RSI near support
  • Attractive dividend yield
  • Limited upside until resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth
  • Valuation discount versus peers
  • Net cash cushion despite high headline leverage

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend policy
  • Value orientation with low P/E and P/B
  • Strategic position in China capital markets

Key Metrics & Analysis

Financial Health

Revenue Growth53.40%
Profit Margin40.15%
P/E Ratio9.8
ROE9.24%
ROA1.65%
Debt/Equity297.41
P/B Ratio0.9
Op. Cash FlowHK$69.3B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI33.7
SupportHK$11.03
ResistanceHK$13.08
MA 20HK$11.91
MA 50HK$12.47
MA 200HK$12.47
MACDBearish
VolumeIncreasing
Fear & Greed Index74.73

Valuation

Fair ValueHK$237.85
Target PriceHK$16.37
Upside/Downside45.26%
GradeUndervalued
TypeBlend
Dividend Yield3.21%

Risk Assessment

Beta0.24
Volatility26.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.